INVO Bioscience Inc
INVO Bioscience, Inc., together with its subsidiary, a healthcare services fertility company, provides assisted reproductive technology solutions worldwide. It offers INVOcell, a medical device that allows fertilization and early embryo development to take place in vivo within the woman's body. The company was founded in 2007 and is based in Sarasota, Florida.
INVO Bioscience Inc (INVO) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2024: 27.484x
Based on the latest financial reports, INVO Bioscience Inc (INVO) has a cash flow conversion efficiency ratio of 27.484x as of September 2024.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-640.81K) by net assets ($-23.32K). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
INVO Bioscience Inc - Cash Flow Conversion Efficiency Trend (2006–2023)
This chart illustrates how INVO Bioscience Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
INVO Bioscience Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of INVO Bioscience Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
InnSuites Hospitality Trust
NYSE MKT:IHT
|
0.988x |
|
Loyal Textile Mills Limited
NSE:LOYALTEX
|
0.064x |
|
Delivra Health Brands Inc
OTCQB:DHBUF
|
-0.064x |
|
EATON CORP -NPV-
MU:3EC
|
0.068x |
|
Joy Industrial Co., Ltd.
TWO:4559
|
0.158x |
|
MODIVCARE INC. DL-001
F:PRF0
|
N/A |
|
LTI0
F:LTI0
|
0.381x |
|
Sulliden Minerals SA
TO:SMC
|
0.090x |
Annual Cash Flow Conversion Efficiency for INVO Bioscience Inc (2006–2023)
The table below shows the annual cash flow conversion efficiency of INVO Bioscience Inc from 2006 to 2023.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2023-12-31 | $892.83K | $-4.76 Million | -5.326x | -178.85% |
| 2022-12-31 | $-977.61K | $-6.60 Million | 6.755x | +918.92% |
| 2021-12-31 | $7.31 Million | $-6.03 Million | -0.825x | +0.80% |
| 2020-12-31 | $5.74 Million | $-4.78 Million | -0.831x | -125.29% |
| 2019-12-31 | $-3.71 Million | $1.37 Million | -0.369x | -253.97% |
| 2018-12-31 | $-2.72 Million | $-652.97K | 0.240x | +560.10% |
| 2017-12-31 | $-4.99 Million | $-181.27K | 0.036x | -10.03% |
| 2016-12-31 | $-3.76 Million | $-151.62K | 0.040x | 0.00% |
| 2015-12-31 | $-3.76 Million | $-151.62K | 0.040x | +806.74% |
| 2014-12-31 | $-4.36 Million | $-19.40K | 0.004x | -71.66% |
| 2013-12-31 | $-3.81 Million | $-59.92K | 0.016x | +22.60% |
| 2012-12-31 | $-3.37 Million | $-43.21K | 0.013x | -68.18% |
| 2011-12-31 | $-2.93 Million | $-117.78K | 0.040x | -68.38% |
| 2010-12-31 | $-2.48 Million | $-315.99K | 0.127x | -55.52% |
| 2009-12-31 | $-3.24 Million | $-926.66K | 0.286x | -81.84% |
| 2008-12-31 | $-676.57K | $-1.07 Million | 1.577x | +438.10% |
| 2007-12-31 | $27.75K | $-12.94K | -0.466x | -1631.37% |
| 2006-12-31 | $37.54K | $-1.01K | -0.027x | -- |